- Home
- Services
- usa massachusetts
- drug administration
Show results for
Refine by
Drug Administration Services In Usa Massachusetts
6 services found
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
At MorphoSys, our mission is to make innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Before these and all other investigational medicinal products can be made broadly available, the U.S. Food and Drug Administration (FDA) and other health authorities around the world require that they are investigated in clinical ...
Manufactured by:Diamond Diagnostics Inc. based inHolliston, MASSACHUSETTS (USA)
Due to tighter healthcare budgets and increased environmental awareness, many laboratories and distributors are pursuing options to extend the use life of instrumentation they currently own. If you are satisfied with the performance of your analyzer, but would like to enhance its appearance and extend its use life considerably, please consider recycling your analyzer with Diamond Diagnostics. In ...
Manufactured by:Akebia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Tenacity: At Akebia, we are inspired to think boldly and move bold thinking into action. We leverage our scientific expertise and this innovative thinking to develop clinical advances in areas that are important to people living with kidney disease. We thrive as collaborators because we believe that we can go further together. We work with partners across the globe to pioneer and grow new areas ...
by:TÜV SÜD America Inc. based inWakefield, MASSACHUSETTS (USA)
In the medical field, practitioners utilize a range of devices to address patient health, from diagnosis to surgery. When the patient comes into contact with a medical device or material, it should fulfill its intended function without harming the patient. Therefore, all medical devices need to undergo a thorough biological risk assessment to protect the patient from any toxic, physiological, ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Biosimilars are biological products that are highly similar to an approved original biological drug (reference or brand drug) without any clinically meaningful differences in quality, safety, or efficacy compared to those approved. Biosimilars typically enter the market after the patent protection period of the original drug has expired, providing a more cost-effective treatment ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Nanoparticles (NPs) undergo interactions with serum proteins during systemic administration, which may result in the formation of protein corona (PC). Investigating the interplay between the chemical and biological properties of NPs enhances clinical translation efficiency. NPs with PC can be considered to exhibit a distinct biological ...